Industrial stocks encompass a wide variety of industries. These include.s aerospace and defense, transportation services, logistics, agriculture, construction and engineering, building products and electrical components. It is a sector that is great for investors looking for a plentiful amount of companies to grow their investment portfolio. Manufacturing, whether cars, medical devices, highways, or airplanes, is a
admin
A day doesn’t go by when another large asset management firm discusses why they are abandoning China for other international stock picks. The reality is that China stocks are out, but you should still consider stocks from other foreign countries. On Jan. 20, Bloomberg reported that Vontobel Asset Management—the Zurich-based asset manager had assets under management
Blue-chip stocks to buy offer greater stability and long-term certainty than smaller equities. These stocks are optimal for buy-and-hold investors. However, investors who monitor the stock market will notice dips from time to time. While dips can cause some investors to panic, savvy individuals recognize these blue-chip stocks to buy dips as buying opportunities. Accumulating
At a cursory look at premium electric vehicle manufacturer Lucid Group (NASDAQ:LCID), it’s easy to become discouraged. Over the past 52 weeks, its equity shares suffered a devastating loss of more than 72%. Fundamentally, the EV price war that Tesla (NASDAQ:TSLA) initiated has come back to bite it in the hind end. Lucid was no
Within the vast landscape of publicly listed companies across the U.S. stock exchanges, sleeper stocks are perhaps the most intriguing. These stocks usually dwell in the shadows due to near-term headwinds yet harbor substantial long-term potential. These sleeper stocks quietly lurk in the investment realm, significantly undervalued and overlooked. While they promise alluring rewards, they
While it’s a relative rarity because price generally discounts everything, that doesn’t mean you can’t find stocks to buy on dip. With thousands upon thousands of securities available, it’s impossible for analysts to track them all with equal weight. Further, the “in” securities tend to attract the most attention. After all, Wall Street isn’t about
Let’s face reality – the very concept of struggling stocks to sell is an ugly one. In many ways, the loyalty to the enterprises in our portfolio is understandable. It’s not just about the money put in, though that obviously plays the biggest factor. Rather, cutting shares out is akin to abandoning your favorite sports
As we enter February 2024, the stock market continues to power ahead, led by Big Tech. However, pockets of overvaluation are appearing, especially with the technology sector trading at 27.5 times the next twelve-month earnings. Considering that starting valuations are a key determinant of forward returns, it’s time to rotate into some undervalued stocks in February 2024.
Newly released documents indicate that the U.S. Food and Drug Administration (FDA) has “determined that cannabis has a legitimate medical use and that it should be moved from Schedule I to Schedule III on the controlled substances list.” With Presidential elections round the corner, there are hopes for federal level legalization of cannabis. Clearly, it’s
Growth stocks can deliver astonishing returns for long-term investors but some of these same investments can crash and burn. These equities may have looked promising a few years ago. However, growth stocks often lose their charm upon significant revenue deceleration or no path to meaningful profits. These stocks are more volatile than the rest of
Technical analysis may still be a controversial idea to some of the old guard but it’s the only methodology I’m aware of that will give you stocks flashing buy signals. Sure, it’s more “factual” for lack of a better word to rely on corporate earnings reports. However, these disclosures only arrive every three months. In
I cannot stress enough how risky OTC stocks or securities traded over the counter really are. For one thing, just the name OTC should ring some alarm bells. This designation means that these securities don’t trade on exchanges like the New York Stock Exchange or the Nasdaq. Instead, they trade via broker-dealer networks. And not
Demand and prices throughout the electric vehicle sector remain muted. While that is generally negative, it also creates opportunities. Currently there are many high quality EV stocks with potential that are trading at a discount. It is in hyperbole to suggest that some of them are trading at once in a lifetime valuations. The sector
According to the renowned consulting firm McKinsey the wellness market is booming. And the firm reports that consumers intend to keep spending more on products that improve their health. McKinsey estimates that the sector’s annual revenue in America has climbed to an extremely impressive $480 billion and is advancing at an annual rate of 5%
The outlook of Lucid (NASDAQ:LCID) stock has definitely improved over the last year. According to my Lucid stock analysis, it will release EVs that have much greater chances of becoming very popular than its current offering. Also importantly, Lucid’s EVs are widely acclaimed as being very attractive, having long driving ranges, and handling very well.
Marathon Digital (NASDAQ:MARA) continues to be in focus as a way for crypto investors to gain exposure to the price of the key commodity it mines – Bitcoin (BTC-USD). With Bitcoin prices remaining volatile, so too has MARA stock in recent weeks. Following the approval of 11 spot Bitcoin ETFs by the Securities and Exchange
When finding stocks to own, growth stocks are a top priority. For those looking to invest with a truly long-term investing time horizon, growth stocks tend to outperform. Companies that can post market-beating growth rates have done incredibly well in recent decades, supported by relatively low-interest rates (that have since headed north). This has led
The market continues to make new all-time highs, but the gains remain lopsided. Some stocks, such as Meta Platforms (NASDAQ:META) are soaring. Yet others, like Moderna (NASDAQ:MRNA), continue to sink. The reality is that mega-cap technology stocks are driving the market at the expense of small-cap stocks and just about every sector of the economy.
Artificial intelligence grabbed most of the headlines last year, but weight loss stocks were equally noteworthy. It grew slowly for several years but really went stratospheric last year. The wider availability of Ozempic and Wegovy set the world on fire. A class of drugs known as glycogen-like peptide-1 (GLP-1) therapies for diabetes and obesity, demand
The Dow Jones Industrial Average, or Dow 30, is meant to be a collection of prestigious blue-chip stocks that represent the U.S. economy well. However, not every company on the Dow is a good investment and is instead one of several doomed Dow stocks. Many stocks have a record of underperformance. So much so that